Small Caps Article: Invion advances skin cancer treatment with positive safety data for INV043 in Phase I/II trial
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Invion. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Invion a question about this update.